Literature DB >> 7722119

Dilated cardiomyopathy is associated with an increase in the type I/type III collagen ratio: a quantitative assessment.

M M Marijianowski1, P Teeling, J Mann, A E Becker.   

Abstract

OBJECTIVES: The aim of this study was to quantify total collagen and the type I/type III collagen ratio and their localization in hearts with dilated cardiomyopathy.
BACKGROUND: Patients with dilated cardiomyopathy have an increase in intramyocardial fibrillar collagen. Types I and III are the main constituents and have different physical properties that may affect cardiac compliance.
METHODS: Nineteen hearts with dilated cardiomyopathy were studied (17 cardiac explants, 2 hearts obtained at autopsy) and compared with reference hearts. Total collagen was determined by hydroxyproline analysis. Collagen types I and III were analyzed using the cyanogen bromide method and immunohistochemical analysis followed by microdensitophotometric quantification. Localization of collagen types I and III was established at the light and electron microscopic levels. Immunoelectron microscopy provided information regarding their localization.
RESULTS: Total collagen and the collagen type I/type III ratio were increased in hearts with dilated cardiomyopathy (p < 0.05). Electron microscopy showed a diffuse increase in collagen fibrils in the endomysium; the perimysium showed an inhomogeneous increase. Collagen fibrils were thicker, and fibrous long-spacing collagen occurred in the endomysium. Immunoelectron microscopic findings confirmed an increase in type I collagen.
CONCLUSIONS: Hearts with dilated cardiomyopathy have a statistically significant increase in the collagen type I/type III ratio. The changes occur in the endomysium and perimysium, although with differences in distribution. These changes in intramyocardial collagen may be clinically relevant because they may affect cardiac rigidity and, therefore, eventually may render the heart less compliant. Further studies are needed to evaluate at what point in the course of the disease these changes appear.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7722119     DOI: 10.1016/0735-1097(94)00557-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  61 in total

1.  Different microcirculatory and interstitial matrix patterns in idiopathic dilated cardiomyopathy and Chagas' disease: a three dimensional confocal microscopy study.

Authors:  M L Higuchi; S Fukasawa; T De Brito; L C Parzianello; G Bellotti; J A Ramires
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

2.  Perinatal changes in mitral and aortic valve structure and composition.

Authors:  Elizabeth H Stephens; Allison D Post; Daniel R Laucirica; K Jane Grande-Allen
Journal:  Pediatr Dev Pathol       Date:  2010-06-10

Review 3.  Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.

Authors:  Razi Khan; Richard Sheppard
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 4.  Myocardial Interstitial Fibrosis in Nonischemic Heart Disease, Part 3/4: JACC Focus Seminar.

Authors:  Javier Díez; Arantxa González; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

5.  Interstitial fibrosis in the dilated non-ischaemic myocardium.

Authors:  A Brooks; V Schinde; A C Bateman; P J Gallagher
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

6.  Passive mechanical properties of cardiac tissues in heart hypertrophy during pregnancy.

Authors:  Adolfo Virgen-Ortiz; J L Marin; A Elizalde; E Castro; E Stefani; L Toro; J Muñiz
Journal:  J Physiol Sci       Date:  2009-06-30       Impact factor: 2.781

7.  Post-mortem evidence of idiopathic left ventricular hypertrophy and idiopathic interstitial myocardial fibrosis: is exercise the cause?

Authors:  Gregory Whyte; Mary Sheppard; Keith George; Robert Shave; Sanjay Prasad; Rory O'Hanlon; Sanjay Sharma
Journal:  BMJ Case Rep       Date:  2009-02-02

8.  A nondenatured, noncrosslinked collagen matrix to deliver stem cells to the heart.

Authors:  Nicholas A Kouris; Jayne M Squirrell; Jangwook P Jung; Carolyn A Pehlke; Timothy Hacker; Kevin W Eliceiri; Brenda M Ogle
Journal:  Regen Med       Date:  2011-09       Impact factor: 3.806

Review 9.  Transient receptor potential (TRP) channels and cardiac fibrosis.

Authors:  Zhichao Yue; Yanhui Zhang; Jia Xie; Jianmin Jiang; Lixia Yue
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

10.  Kinetics of selected serum markers of fibrosis in patients with dilated cardiomyopathy and different grades of diastolic dysfunction of the left ventricle.

Authors:  Sylwia Wiśniowska-Śmiałek; Ewa Dziewięcka; Katarzyna Holcman; Ewa Wypasek; Lusine Khachatryan; Aleksandra Karabinowska; Maria Szymonowicz; Agata Leśniak-Sobelga; Marta Hlawaty; Magdalena Kostkiewicz; Piotr Podolec; Paweł Rubiś
Journal:  Cardiol J       Date:  2018-11-28       Impact factor: 2.737

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.